Drug Trial Radar · NCT07028749
Study of MAR001 in Adults With Elevated Triglycerides and Remnant Cholesterol
Last checked: Nov 19, 2026Latest source record: Sep 2, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
316
Planned (sponsor's estimate)
Start
Jun 30, 2025
Primary completion
Nov 2027
Study completion Apr 2028
Sponsor
- Lead sponsor
- Marea TherapeuticsIndustry
- Sponsor type
- Industry
- Collaborators
- The TIMI Study Group
- First posted
- Jun 19, 2025
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The primary objective of the study is to evaluate the effect of MAR001 compared to placebo on levels of TG in adults with elevated TG and RC.
Conditions
- Hypertriglyceridemia
Interventions
MAR001Drug
Subcutaneous Injection
PlaceboDrug
Subcutaneous injection
Primary outcomes
What the sponsor says the trial is designed to measure.
- Primary EndpointTime frame: 12 weeks
Locations
55 sites in 4 countries. Site status is shown where the registry gives one.
Marea Site 328
Anniston, Alabama · Active not recruiting
Marea Site 329
Mobile, Alabama · Active not recruiting
Marea Site 313
Little Rock, Arkansas · Active not recruiting
Marea Site 306
Hamden, Connecticut · Active not recruiting
Marea Site 302
Boca Raton, Florida · Recruiting
Marea Site 307
Port Saint Lucie, Florida · Recruiting
Marea Site 310
Columbus, Georgia · Active not recruiting
Marea Site 319
Peachtree Corners, Georgia · Recruiting
Marea Site 317
Park Ridge, Illinois · Active not recruiting
Marea Site 325
Springfield, Illinois · Recruiting
Marea Site 301
Louisville, Kentucky · Active not recruiting
Marea Site 316
Baltimore, Maryland · Active not recruiting
Marea Site 330
Kansas City, Missouri · Active not recruiting
Marea Site 305
St Louis, Missouri · Recruiting
Marea Site 304
Great Neck, New York · Active not recruiting
Marea Site 318
New Windsor, New York · Active not recruiting
Marea Site 303
Greensboro, North Carolina · Active not recruiting
Marea Site 315
Winston-Salem, North Carolina · Active not recruiting
Marea Site 314
Greenville, South Carolina · Active not recruiting
Marea Site 320
Little River, South Carolina · Recruiting
Marea Site 326
Memphis, Tennessee · Recruiting
Marea Site 322
Amarillo, Texas · Active not recruiting
Marea Site 308
McKinney, Texas · Active not recruiting
Marea Site 312
San Antonio, Texas · Active not recruiting
Marea Site 321
Manassas, Virginia · Active not recruiting
Marea Site 309
Tacoma, Washington · Active not recruiting
Marea Site 103
Canberra, Australian Capital Territory, Australia · Active not recruiting
Marea Site 105
Kanwal, New South Wales, Australia · Active not recruiting
Marea Site 107
Merewether, New South Wales, Australia · Active not recruiting
Marea Site 106
Miranda, New South Wales, Australia · Active not recruiting
Marea Site 109
Wollongong, New South Wales, Australia · Active not recruiting
Marea Site 108
Herston, Queensland, Australia · Active not recruiting
Marea Site 104
Milton, Queensland, Australia · Recruiting
Marea Site 111
Leabrook, South Australia, Australia · Recruiting
Marea Site 102
Clayton, Victoria, Australia · Recruiting
Marea Site 110
Heidelberg Heights, Victoria, Australia · Active not recruiting
Marea Site 113
Hoppers Crossing, Victoria, Australia · Active not recruiting
Marea Site 101
Nedlands, Western Australia, Australia · Recruiting
Marea Site 112
Perth, Western Australia, Australia · Recruiting
Marea Site 406
Concord, Ontario, Canada · Recruiting
Showing 40 of 55 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.